Table A2.

Summary of seroreactivity for subjects in Group 1 (Bbsl), Group 2 (RFB), or both.

Immunoblot	Total
Group 1 Bbsl positive	42
Group 2 RFB positive	56
Dual Group 1 and 2 positive	8
Group 1 Bbsl positive samples	34 (38%)
Bbsl alone	8
Bbss alone	4
B. afzelii/garinii alone	6
B. californiensis alone	6
B. spielmanii alone	6
B. mayonii + B. speilmanii	2
B. spielmanii + B. afzelii/garinii	1
B. afzelii/garinii, B. californiensis, B. mayonii	1
Group 2. RFB Positive Samples	48 (53%)
RFB alone	25
B. hermsii alone	7
B. miyamotoi alone	4
B. turicatae alone	8
B. turcica alone	2
B. hermsii + B. turcica	1
B. hermsii + B. miyamotoi	1
Dual Group 1 and 2	8 (9%)
Bb + RFB	2
Bb + B. hermsii	1
B. californiensis + RFB	2
B. spielmanii + RFB	1
B. afzelii/garinii + RFB	1
B. afzelii/garinii + B. turicatae	1
Total cases	90